HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ATR checkpoint kinase and CRL1βTRCP collaborate to degrade ASF1a and thus repress genes overlapping with clusters of stalled replication forks.

Abstract
Many agents used for chemotherapy, such as doxorubicin, interfere with DNA replication, but the effect of this interference on transcription is largely unknown. Here we show that doxorubicin induces the firing of dense clusters of neoreplication origins that lead to clusters of stalled replication forks in gene-rich parts of the genome, particularly on expressed genes. Genes that overlap with these clusters of stalled forks are actively dechromatinized, unwound, and repressed by an ATR-dependent checkpoint pathway. The ATR checkpoint pathway causes a histone chaperone normally associated with the replication fork, ASF1a, to degrade through a CRL1(βTRCP)-dependent ubiquitination/proteasome pathway, leading to the localized dechromatinization and gene repression. Therefore, a globally active checkpoint pathway interacts with local clusters of stalled forks to specifically repress genes in the vicinity of the stalled forks, providing a new mechanism of action of chemotherapy drugs like doxorubicin. Finally, ASF1a-depleted cancer cells are more sensitive to doxorubicin, suggesting that the 7%-10% of prostate adenocarcinomas and adenoid cystic carcinomas reported to have homozygous deletion or significant underexpression of ASF1a should be tested for high sensitivity to doxorubicin.
AuthorsJun-Sub Im, Mignon Keaton, Kyung Yong Lee, Pankaj Kumar, Jonghoon Park, Anindya Dutta
JournalGenes & development (Genes Dev) Vol. 28 Issue 8 Pg. 875-87 (Apr 15 2014) ISSN: 1549-5477 [Electronic] United States
PMID24700029 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • ASF1A protein, human
  • Antineoplastic Agents
  • Cell Cycle Proteins
  • Histones
  • Molecular Chaperones
  • Doxorubicin
  • CULL-RING ligase, human
  • Ubiquitin-Protein Ligases
  • ATR protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • RNA Polymerase II
Topics
  • Antineoplastic Agents (pharmacology)
  • Ataxia Telangiectasia Mutated Proteins (metabolism)
  • Cell Cycle Checkpoints (genetics)
  • Cell Cycle Proteins (genetics, metabolism)
  • Cell Line, Tumor
  • Cells (drug effects)
  • DNA Replication (genetics)
  • Doxorubicin (pharmacology)
  • Gene Expression Regulation, Neoplastic (drug effects, genetics)
  • Gene Knockdown Techniques
  • HeLa Cells
  • Histones (metabolism)
  • Humans
  • Molecular Chaperones
  • RNA Polymerase II (metabolism)
  • Replication Origin (genetics)
  • Ubiquitin-Protein Ligases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: